Updates

Medica

November 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Nice to note that the private equity backer CBPE is almost out (holding down from 11% to 7.4%) and the often astute Old Mutual now holds 17.4%.The company reported its H1 results with sales +17% to £15.7m and adjusted pretax profit +5% to £4.3m with management noting a material acceleration in run-rate from Q1 to Q2 and that Q3 trading is strong. This is supported by the increase in radiologists with 19 (net) added in H1 and a very impressive 24 already in H2 to date - leaving it well set for its 300 target by the end of the year (from 250 at the end of 2016). The success driver is the NightHawk and Cross Sectional verticals where volume (in terms of body parts scanned) grew 26% and 31%, respectively (sales ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Luceco - Acquires LED street lighting supplier on 6x operating profit

RWS - Reports best ever year

Medica - Bid at 212p (May 2023)

Medica - Moves into US$1bn US clinical trials market (May 2021)

Medica (November 2020)

Medica Group (August 2020)

Medica (September 2018)

Medica - Radiology recruitment jumps in Q2 (May 2018)

Medica (February 2018)

Medica - Sets up advanced practitioner radiography network alongside radiologist one (May 2017)

Medica - Hot telehealth new issue (April 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X